Denise M Boudreau

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Collaborative care model to improve outcomes in major depression
    Denise M Boudreau
    Department of Pharmacy, University of Washington, Seattle, WA 98195 7630, USA
    Ann Pharmacother 36:585-91. 2002
  2. ncbi Measurement of opioid problems among chronic pain patients in a general medical population
    Caleb J Banta-Green
    Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105, USA
    Drug Alcohol Depend 104:43-9. 2009
  3. ncbi Cardiovascular medication use and risk for colorectal cancer
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 17:3076-80. 2008
  4. ncbi Cost of breast-related care in the year following false positive screening mammograms
    Jessica Chubak
    Group Health Research Institute, Seattle, WA 98101 1448, USA
    Med Care 48:815-20. 2010
  5. ncbi Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care
    Kam L Capoccia
    Departments of Pharmacy and Family Medicine, University of Washington, Seattle, USA
    Am J Health Syst Pharm 61:364-72. 2004
  6. ncbi Colorectal cancer risk in relation to antidepressant medication use
    Jessica Chubak
    Group Health Research Institute, Group Health, Seattle, WA 98101 1448, USA
    Int J Cancer 128:227-32. 2011
  7. ncbi The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Cancer 100:2308-16. 2004
  8. ncbi Statin use and breast cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 16:416-21. 2007
  9. ncbi Statin use and cancer risk: a comprehensive review
    Denise M Boudreau
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Expert Opin Drug Saf 9:603-21. 2010
  10. ncbi Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes
    Denise M Boudreau
    Department of Pharmacy, University of Washington, Seattle, WA, USA
    J Am Geriatr Soc 59:2069-76. 2011

Detail Information

Publications24

  1. ncbi Collaborative care model to improve outcomes in major depression
    Denise M Boudreau
    Department of Pharmacy, University of Washington, Seattle, WA 98195 7630, USA
    Ann Pharmacother 36:585-91. 2002
    ..To develop a pharmacist intervention to improve depression care and outcomes within a primary care setting...
  2. ncbi Measurement of opioid problems among chronic pain patients in a general medical population
    Caleb J Banta-Green
    Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105, USA
    Drug Alcohol Depend 104:43-9. 2009
    ..The utility of the PDUQ and its relationship with the DSM-IV approach needs to be established for patients being treated in general medical settings...
  3. ncbi Cardiovascular medication use and risk for colorectal cancer
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 17:3076-80. 2008
    ..We hypothesized a reduction in colorectal cancer risk with 3-hydroxy-3-methylglutaryl coA reductase inhibitors (statins) and angiotensin-converting enzyme inhibitors...
  4. ncbi Cost of breast-related care in the year following false positive screening mammograms
    Jessica Chubak
    Group Health Research Institute, Seattle, WA 98101 1448, USA
    Med Care 48:815-20. 2010
    ..We sought to estimate the direct cost, from the perspective of the health insurer or purchaser, of breast-care services in the year following a false positive screening mammogram compared with a true negative examination...
  5. ncbi Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care
    Kam L Capoccia
    Departments of Pharmacy and Family Medicine, University of Washington, Seattle, USA
    Am J Health Syst Pharm 61:364-72. 2004
    ..CONCLUSION: Frequent telephone contacts and interventions by pharmacists and UC in a primary care setting resulted in similar rates of adherence to antidepressant regimens and improvements in the outcomes of depression at one year...
  6. ncbi Colorectal cancer risk in relation to antidepressant medication use
    Jessica Chubak
    Group Health Research Institute, Group Health, Seattle, WA 98101 1448, USA
    Int J Cancer 128:227-32. 2011
    ..Future studies with larger sample sizes should further examine individual drugs as well as dose, duration and recency of use...
  7. ncbi The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Cancer 100:2308-16. 2004
    ..However, statins have been found to be carcinogenic in rodents and one clinical trial found an excess of breast carcinoma cases in the treatment group...
  8. ncbi Statin use and breast cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 16:416-21. 2007
    ..Mechanistic studies suggest that 3-hydroxy-3-methylglutaryl CoA inhibitors (statins) reduce the risk of breast cancer. Observational studies offer mixed results...
  9. ncbi Statin use and cancer risk: a comprehensive review
    Denise M Boudreau
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Expert Opin Drug Saf 9:603-21. 2010
    ..They are among the most commonly prescribed drugs worldwide. Contrary to early concerns over the carcinogenicity of statins, a growing body of evidence suggests statins may in fact have a chemopreventive potential against cancer...
  10. ncbi Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes
    Denise M Boudreau
    Department of Pharmacy, University of Washington, Seattle, WA, USA
    J Am Geriatr Soc 59:2069-76. 2011
    ..To determine the extent of concomitant use of cholinesterase inhibitor (ChI) and anticholinergic (ACh) medications and the clinical consequences of dual use in a population-based setting...
  11. ncbi Antidepressant use and breast cancer risk
    Chloe Chien
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Breast Cancer Res Treat 95:131-40. 2006
    ..However, human studies evaluating use of antidepressants in relation to breast cancer risk have yielded inconsistent results...
  12. ncbi Statin use and female reproductive organ cancer risk in a large population-based setting
    Onchee Yu
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Cancer Causes Control 20:609-16. 2009
    ..We evaluated the association between statin use and endometrial as well as ovarian cancer risks...
  13. ncbi Statin use and prostate cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Cancer Causes Control 19:767-74. 2008
    ..Statins are a commonly used cholesterol-lowering drug, which also have the potential to affect cancer risk and progression. Results from previous studies offer mixed conclusions...
  14. ncbi The influence of statin use on breast density
    Denise M Boudreau
    Group Health Cooperative, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 15:1026-9. 2006
    ..To evaluate if 3-hydroxy-3-methylglutaryl CoA reductase reductase inhibitor use (statins) alters mammography measured breast density...
  15. ncbi Concordance of population-based estimates of mammography screening
    Denise M Boudreau
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    Prev Med 45:262-6. 2007
    ..This study estimated adherence to repeat (two successive on-time screenings) and regular screening (three or more successive screenings) and evaluated the impact of varying operational definitions and evaluation periods...
  16. ncbi Breast cancer recurrence risk in relation to antidepressant use after diagnosis
    Jessica Chubak
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101 1448, USA
    Breast Cancer Res Treat 112:123-32. 2008
    ....
  17. ncbi Cardiovascular events associated with ipratropium bromide in COPD
    Sarika S Ogale
    Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA
    Chest 137:13-9. 2010
    ..We sought to examine the association between ipratropium bromide use and the risk of cardiovascular events (CVEs)...
  18. ncbi Impact of hormone therapy on false-positive recall and costs among women undergoing screening mammography
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101 1448, USA
    Med Care 44:62-9. 2006
    ..We sought to evaluate the effects of hormone therapy (HT) on false-positive (FP) recall for additional breast evaluation and costs...
  19. ncbi A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke
    Denise M Boudreau
    University of Washington, Seattle, WA, USA
    Ann Emerg Med 61:46-55. 2013
    ..We evaluate the long-term incremental cost-effectiveness of rtPA administered 3 to 4.5 hours after acute ischemic stroke onset versus no treatment according to patient clinical and demographic factors...
  20. ncbi Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients
    Caleb J Banta-Green
    Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105, USA
    Drug Alcohol Depend 104:34-42. 2009
    ..Aims were to improve our understanding of this population as well as to explore ways of identifying different types of patients...
  21. ncbi The cost-effectiveness of primary stroke centers for acute stroke care
    Gregory F Guzauskas
    University of Washington, Seattle, WA 98195, USA
    Stroke 43:1617-23. 2012
    ..The objective of this study was to evaluate the cost-effectiveness of treating AIS patients in a PSC compared with a nonPSC hospital setting...
  22. ncbi Accuracy of ICD-9 codes to identify nonunion and malunion and developing algorithms to improve case-finding of nonunion and malunion
    Denise M Boudreau
    Group Health Research Institute, Seattle, WA 98101, USA
    Bone 52:596-601. 2013
    ..To evaluate the accuracy of using ICD-9 codes to identify nonunions (NU) and malunions (MU) among adults with a prior fracture code and to explore case-finding algorithms...
  23. ncbi Colorectal cancer risk in relation to use of acid suppressive medications
    Jessica Chubak
    Group Health Center for Health Studies, Seattle, WA 98101 1448, USA
    Pharmacoepidemiol Drug Saf 18:540-4. 2009
    ..A few epidemiologic studies have investigated acid suppressant use and CRC risk; none has documented an overall association. We sought to investigate whether acid suppressants are associated with CRC risk...
  24. ncbi A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Am J Epidemiol 159:308-17. 2004
    ..Trivial changes in estimates were observed when health maintenance organization records alone were used as the gold standard. Self-reported use of antihypertensives and statins appears to be relatively accurate among older women...